Table 1.
Patients characteristics
| All patients (n = 35) | No MR (n = 15) | Significant MR (n = 20) | p | |
|---|---|---|---|---|
| Age (years) | 44.0 ± 23.0 | 38.1 ± 19.1 | 48.5 ± 25.1 | 0.19 |
| Height (cm) | 174.5 ± 12.4 | 178.1 ± 13.2 | 171.9 ± 11.4 | 0.14 |
| Weight (kg) | 62.4 ± 15.9 | 64.5 ± 18.8 | 60.8 ± 13.7 | 0.5 |
| BMI (kg/m2) | 20.3 ± 3.8 | 20.1 ± 4.3 | 20.4 ± 3.4 | 0.82 |
| LVEDV (ml) | 155.4 ± 51.1 | 151.5 ± 58.3 | 158.4 ± 46.3 | 0.7 |
| LVEDV index (ml/m2) | 88.5 ± 22.8 | 83.4 ± 22.6 | 92.2 ± 22.8 | 0.27 |
| LVESV uncorrected (ml) | 53.3 ± 23.3 | 50.9 ± 25.6 | 55.0 ± 22.0 | 0.62 |
| LVESV corrected (ml) | 69.8 ± 28.4 | 65.3 ± 29.7 | 73.1 ± 27.8 | 0.43 |
| LVEF standard (%) | 66.4 ± 7.3 | 67.2 ± 7.1 | 65.7 ± 7.6 | 0.56 |
| LVEF corrected (%) | 55.6 ± 8.3 | 57.6 ± 7.2 | 54.1 ± 8.9 | 0.22 |
| Prolapsed height (mm) | 8.1 ± 2.8 | 7.6 ± 2.1 | 8.5 ± 3.2 | 0.32 |
| Prolapsed volume (ml) | 16.5 ± 8.7 | 14.4 ± 7.0 | 18.1 ± 9.6 | 0.22 |
| RVEDV (ml) | 140.1 ± 46.3 | 157.4 ± 55.6 | 127.2 ± 33.8 | 0.05 |
| RVESV (ml) | 68.6 ± 24.5 | 73.8 ± 28.7 | 64.7 ± 20.9 | 0.29 |
| RVEF (%) | 51.0 ± 6.6 | 53.5 ± 5.3 | 49.1 ± 7.0 | 0.05 |
| Indication for CMR (n; %) | ||||
| • Marfan syndrome | 11 (31) | 6 (40) | 5 (25) | 0.02 |
| • MR quantification | 9 (26) | 0 (0) | 9 (45) | |
| • Ventricular arrhythmia | 7 (20) | 6 (40) | 1 (5) | |
| • Ischemia detection | 5 (14) | 2 (13) | 3 (15) | |
| • Suspicion of myocarditis | 1 (3) | 0 (0) | 1 (5) | |
| • Malformation syndromes | 2 (6) | 1 (7) | 1 (5) | |